ELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits

Gajkowski, Evan; Herrera, Guillermo A.; Hatton, Laura; Antonini, Marta Velia; Vercaemst, Leen; Cooley, Elaine

doi:10.1097/mat.0000000000001630

Cited by 88 publications

(74 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Standardized protocols for io VA ECMO and immunosuppressive therapy have been developed in our center following international recommendations [ 1 , 4 , 5 , 13 , 14 , 17 , 18 ].…”

Section: Methodsmentioning

confidence: 99%

“…In particular, many efforts have been made to clarify the applicability and benefits of intraoperative (io) veno-arterial extracorporeal membrane oxygenation (VA ECMO), using it not only as a ‘rescue’ device helpful for managing acute life-threatening complications (i.e., pulmonary hypertension with right ventricular failure) but also as an io extracorporeal support routinely applicable ‘in advance’ for every patient [ 3 , 4 , 5 , 6 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Impact of New Treatments on Short- and MID-Term Outcomes in Bilateral Lung Transplant: A Propensity Score Study

Boscolo

Amore

Pettenuzzo

et al. 2022

JCM

View full text Add to dashboard Cite

Background: Despite many efforts to improve organ preservation and recipient survival, overall lung transplant (LT) mortality is still high. We aimed to investigate the impact of ‘prophylactic’ veno-arterial extracorporeal membrane oxygenation (VA ECMO) and tacrolimus on 72-h primary graft dysfunction (PGD) and 30-day acute cellular rejection, respectively. Methods: All consecutive LT patients admitted to the Intensive Care Unit of the Padua University Hospital (February, 2016–2022) were screened. Only adult patients undergoing first bilateral LT and not requiring cardio-pulmonary bypass, invasive mechanical ventilation, and/or ECMO before LT, were included. A propensity score weighting analysis was employed to account for the non-random allocation of the subjects to different treatments. Results: A total of 128 LT recipients were enrolled. Compared to the ‘off-pump’-group (n.47, 37%), ‘prophylactic’ VA ECMO (n.51,40%) recorded similar 72-h PGD values, perioperative blood products and lower acute kidney dysfunction. Compared with cyclosporine (n.86, 67%), tacrolimus (n.42, 33%) recorded a lower risk of 30-day cellular rejection, kidney dysfunction, and bacteria isolation. Conclusions: ‘Prophylactic’ VA ECMO recorded 72-h PGD values comparable to the ‘off-pump’-group; while tacrolimus showed a lower incidence of 30-day acute cellular rejection.

show abstract

“…Standardized protocols for io VA ECMO and immunosuppressive therapy have been developed in our center following international recommendations [ 1 , 4 , 5 , 13 , 14 , 17 , 18 ].…”

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The Impact of New Treatments on Short- and MID-Term Outcomes in Bilateral Lung Transplant: A Propensity Score Study

Boscolo

Amore

Pettenuzzo

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

“…Augmentation of distal blood flow can be achieved by placing an antegrade distal perfusion catheter in the artery distal to the ECMO cannula. 29…”

Section: Complicationsmentioning

confidence: 99%

Extracorporeal membrane oxygenation in children: A brief review

Sakurai

Singhal

2022

J Paediatrics Child Health

View full text Add to dashboard Cite

With the advancement in technology and increasing familiarity, the use of extracorporeal membrane oxygenation (ECMO) has expanded in the past decade. Although ECMO can be lifesaving for critically ill children, it is an invasive therapy associated with complications that may necessitate rehabilitation and long‐term follow‐up. Paediatric clinicians play an essential role in managing these children, especially after the acute phase of their illness. This review provides an overview of ECMO and will provide a basic understanding of ECMO and its principles.

show abstract

“…VV-ECMO is indicated for the treatment of patients with any potentially reversible respiratory complication where the lungs are unable to provide sufficient ventilation and oxygenation despite the use of conventional treatment ( 25 ). The main indications of ECMO in respiratory support are divided into: (1) rescue of patients with refractory hypoxemia suffering from inadequate arterial oxygenation despite optimal levels of inspired oxygen, (2) rescue of patients with refractory hypercapnia leading to high CO 2 blood levels, (3) rescue of patients from injurious mechanical ventilation ( 24 ).…”

Section: Medical Backgroundmentioning

confidence: 99%

Trends, Advantages and Disadvantages in Combined Extracorporeal Lung and Kidney Support From a Technical Point of View

Costa

Halfwerk

Wiegmann

et al. 2022

Front. Med. Technol.

View full text Add to dashboard Cite

Extracorporeal membrane oxygenation (ECMO) provides pulmonary and/or cardiac support for critically ill patients. Due to their diseases, they are at high risk of developing acute kidney injury. In that case, continuous renal replacement therapy (CRRT) is applied to provide renal support and fluid management. The ECMO and CRRT circuits can be combined by an integrated or parallel approach. So far, all methods used for combined extracorporeal lung and kidney support present serious drawbacks. This includes not only high risks of circuit related complications such as bleeding, thrombus formation, and hemolysis, but also increase in technical workload and health care costs. In this sense, the development of a novel optimized artificial lung device with integrated renal support could offer important treatment benefits. Therefore, we conducted a review to provide technical background on existing techniques for extracorporeal lung and kidney support and give insight on important aspects to be addressed in the development of this novel highly integrated artificial lung device.

show abstract

ELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits

Cited by 88 publications

References 4 publications

The Impact of New Treatments on Short- and MID-Term Outcomes in Bilateral Lung Transplant: A Propensity Score Study

The Impact of New Treatments on Short- and MID-Term Outcomes in Bilateral Lung Transplant: A Propensity Score Study

Extracorporeal membrane oxygenation in children: A brief review

Trends, Advantages and Disadvantages in Combined Extracorporeal Lung and Kidney Support From a Technical Point of View

Contact Info

Product

Resources

About